Journal of Advanced Research · 2024 · 20 citations · 28 references
MedicineImmunologyOncologyMetastasisSignal TransductionTumor MicroenvironmentCancer Cell SignalingImmune Cell InfiltrationMacrophage BiologyMetastatic Signaling PathwaysTumor Immune MicroenvironmentTumor-associated MacrophagesCancer-associated MacrophagesLipid Metabolism PathwaysMacrophage MetabolismMacrophage Signaling PathwaysMetabolic Signaling In MetastasisMetastasis PromotionMonocyte InfiltrationMonocyte-derived Macrophages
The graphical abstract describes how CD36 mediated monocyte mobilization by activating p110y in a lipid raft dependent manner, providing a therapeutic potential of targeting CD36 against liver metastasis. • CD36 expression is associated with the accumulation of TAMs in patients with liver metastasis. • Circulating monocyte-differentiated macrophages contributes to liver metastasis. • CD36 deletion specifically attenuates the population of monocyte-differentiated macrophages. • CD36 mediates monocyte infiltration through the CCL2/CCR2/p110γ axis. • CD36 activates p110γ signaling in a lipid raft-dependent manner. Metabolic regulators are key in controlling immune cell fate in the tumor microenvironment. The accumulation of tumor-associated macrophages (TAMs) in cancer greatly contributes to metastasis and poor outcome. However, the metabolic pathways responsible for TAM accumulation are largely unknown. This study aims to elucidate the role of the fatty acid translocase CD36 in the regulation of TAM accumulation. The immune profile was analyzed in patients with liver metastasis by CIBERSORT. Immunohistostaining of CD68 and CD36 was conducted in clinical specimens from patients with liver metastasis. Myeloid-specific CD36 knockout mice and their littermates were used to establish preclinical liver metastasis models. Subsequently, a series of experiments were used to explore the underlying mechanisms of how CD36 regulates TAM population. We found that massive TAM accumulation in patients with liver metastasis is associated with an upregulation of CD36 on TAMs. Liver metastasis is abundantly infiltrated by TAMs that are derived from circulating monocytes, but not tissue-resident macrophages. Myeloid-specific CD36 knockout specifically reduced and inactivated monocyte-differentiated macrophages, resulting in diminished immune suppression and attenuated liver metastasis. The protect effects of CD36 knockout can be abrogated by blockade of macrophage recruitment through CCR2 or the p110γ isoform of PI3K downstream of it. Mechanically, CD36 reprogrammed the lipid metabolism of macrophages, in which sphingolipids were significantly downregulated, that contributed to weakened lipid raft-dependent activation of p110γ. CD36 expands TAM population by promoting the recruitment of circulating monocytes through CCL2/CCR2/p110γ signaling. Our findings provide evidence for targeting CD36 as a therapeutic strategy against liver metastasis.
28
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual, Alexandra Avgustinova, Stefania Mejetta et al. · Nature · 2016 · 1.4K citations
Medicine, Cancer Biology, Oncology +14
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Jiali Yu, Michael D. Green, Shasha Li et al. · Nature Medicine · 2021 · 973 citations · Full text
Medicine, Immunology, Oncology +16